Journal
AMERICAN JOURNAL OF EPIDEMIOLOGY
Volume 160, Issue 4, Pages 368-375Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/aje/kwh213
Keywords
cohort studies; diet; folic acid; homocysteine; Parkinson disease
Categories
Funding
- NCI NIH HHS [CA87969] Funding Source: Medline
- NINDS NIH HHS [NS35624] Funding Source: Medline
Ask authors/readers for more resources
In clinical studies, individuals with Parkinson's disease have had higher concentrations of plasma homocysteine than did controls, and experimental evidence suggests that folate deficiency or focal administration of homocysteine sensitizes dopaminergic neurons to the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The authors thus prospectively investigated whether higher intake of folate, vitamin B-6, or vitamin B-12 was related to a lower risk of Parkinson's disease in the Health Professionals Follow-up Study (1986-2000) and the Nurses' Health Study (1980-1998). They documented Parkinson's disease diagnoses in 248 men and 167 women during the follow-up. Folate intake was not associated with the risk of Parkinson's disease; the relative risks for the highest compared with the lowest quintiles were 1.0 (95% confidence interval: 0.7, 1.5) in men and 1.3 (95% confidence interval: 0.8, 2.3) in women. Neither did they find significant associations in analyses stratified by age, smoking, alcohol consumption, or lactose intake. Intake of vitamin B-6 or vitamin B-12 also was not related to the risk of Parkinson's disease. The current study does not support the hypothesis that higher intake of folate or related B vitamins lowers the risk of Parkinson's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available